The Chemokine MIG is Associated with an Increased Risk of COVID-19 Mortality in Mexican Patients.

导出 LinkOut

翻译打印收藏纠错

第一作者： Luis Antonio,Ochoa-Ramirez

第一单位： Genomic Medicine Laboratory, Culiacan General Hospital, Sinaloa, Mexico.

作者： Luis Antonio,Ochoa-Ramirez ^[1] ; Rosalio,Ramos-Payan ^[2] ; German Reynaldo,Jimenez-Gastelum ^[3] ; Jose,Rodriguez-Millan ^[4] ; Maribel,Aguilar-Medina ^[2] ; Juan Jose,Rios-Tostado ^[5] ; Alfredo,Ayala-Ham ^[3] ; Mercedez,Bermudez ^[6] ; Juan Fidel,Osuna-Ramos ^[7] ; Vicente,Olimon-Andalon ^[3] ; Jesús Salvador,Velarde-Félix ^[5]

作者单位： Genomic Medicine Laboratory, Culiacan General Hospital, Sinaloa, Mexico. ^[1] Faculty of Chemical and Biological Sciences, Autonomous University of Sinaloa, Mexico ^[2] Faculty of Biology, Autonomous University of Sinaloa, Mexico ^[3] Department of Internal Medicine, Culiacan General Hospital, Sinaloa, Mexico ^[4] Genomic Medicine Laboratory, Culiacan General Hospital, Sinaloa, Mexico.;Faculty of Biology, Autonomous University of Sinaloa, Mexico ^[5] Faculty of Odontology, Autonomous University of Chihuahua, Mexico ^[6] Department of Infectomics and Molecular Pathogenesis, Center for Research and Advanced Studies, Mexico City, Mexico ^[7]

关键词 Chemokine COVID-19 IP-10 MCP-1 MIG

主题词趋化因子CCL5(Chemokine CCL5);趋化因子CXCL10(Chemokine CXCL10);趋化因子CXCL9(Chemokine CXCL9);人类(Humans);白细胞介素8(Interleukin-8);墨西哥(Mexico)

DOI 10.22034/iji.2022.92641.2162

PMID 36190384

发布时间 2022-10-12

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交